A68S (p.Ala68Ser) variant of MPL (Thrombopoietin receptor)

A68S (p.Ala68Ser) in MPL (Thrombopoietin receptor) is a missense change. Clinical records from ClinVar and UniProt describe it as uncertain significance in the context of Inborn genetic diseases. The available variant effect predictions contribute to a CATVariant prioritization score of 0.42 / 1. The record also includes population frequency data and structural context.

A68S (p.Ala68Ser) variant details